Olaparib is a drug used to treat breast and ovarian cancer. Scientists at Cancer Research UK have found that the drug is much more effective at stopping the growth of prostate cancer than hormone therapy.

Ovarian cancer is the most common disease in women of reproductive age, after cervical cancer. Olaparib is considered an effective adjuvant treatment for ovarian cancer.